Healthy Skepticism Library item: 17628

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Corbett Dooren J
FDA Chides Glaxo for Cancer-Drug Ad
The Wall Street Journal 2010 Apr 16
http://online.wsj.com/article/SB10001424052702303491304575188501070131496.html

Abstract:

The Food and Drug Administration on Friday said an advertisement for a GlaxoSmithKline PLC cancer drug and a Web site for a bladder treatment the company co-promotes were “false or misleading.”

The agency also took issue with a consumer email from Novartis AG about its pain gel Voltaren.

Specifically, an advertisement that ran in a cancer medical journal involving Glaxo’s drug Arzerra omitted “important information about the drug’s safety and effectiveness,” the FDA said in a letter to the company that was posted on the agency’s Web site. Arzerra was approved in October to …